Atlas Trials

Resveratrol, Cardiovascular Risk Markers And Cognitive Performance In Patients With Schizophrenia

Clinical trial NCT02062190 · COMPLETED

Trial details

NCT number
NCT02062190
Sponsor
Federal University of Rio Grande do Sul
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2014-03-01
Primary completion
2015-01-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.